Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases, commercializing advanced therapies to treat a range of devastating rare and orphan diseases. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $430M, Post-IPO Debt

Round Investors: Blackstone Credit (lead), Blackstone Life Sciences (lead)

🚀Growth Focus: Grow its overall revenues, refinance its debt, and move toward profitability.

Press: Yahoo Finance, Fierce Pharma

HQ: Princeton, NJ

Industry: Biotechnology Research

Employee Count: 601

Canoo operates a mobility technology company that develops breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that spans the full lifecycle of the vehicle. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $45M, Post-IPO Equity

Round Investors: [Not Disclosed]

🚀Growth Focus: Accelerate development toward its mission, showcasing a disciplined, milestone-focused capital approach aligning with the phased manufacturing capacity increase needed to meet customer demand.

Press: PR Newswire, Canoo Press

HQ: Justin, TX

Industry: Motor Vehicle Manufacturing

Employee Count: 670 (⚡10% increase in last 6 months)

🔥Open Sales Gigs: Currently Hiring